We recently hosted an insightful webinar in partnership with Sharewise, where our Managing Director, Mathew Cherian, provided a comprehensive market update on Global Health Limited (ASX:GLH). The session covered our strategic vision, future growth plans, and key initiatives aimed at driving our success in the...
View the market update presentation here: Oct-24 Investor Market Update....
Global Health Limited (GLH:ASX) presented at the Microcap Investor Conference today to discuss the company’s latest updates and results for 2022. View full presentation here....
Global Health Limited is pleased to present our full year-2022 annual report and business update. Financial highlights A year of investment, following a capital raising, has delivered a material increase in sales, marketing and software development capability. Reduced professional service revenue in FY22 impacted the top line,...
Michael Davies, CEO of Global Health caught up with Ky Chow from Proactive Investors to discuss the company's latest 4C Quarterly results. Michael discusses the growth in our sales pipeline, the steps we are taking to re-platform and revolutionise our R&D, our successful implementation of MasterCare...
Read our latest Investor Presentation here....
Watch the video. Listen to CEO Michael Davies as he provides an update six months into his new role. Learn how Michael is leading the team, leveraging sales and marketing capabilities, investing in research and development, and positioning our product portfolio for growth. The update includes information...
Global Health’s CEO Michael Davies talks to Proactive Investors about the company’s main mission; to deliver healthcare software for clinicians, community health organisations and administrators at the more complex end of the market. Watch the video. ...
Luke Winchester from Merewether Capital reviews how Global Health grew its revenue by 25% despite COVID-19 limitations in FY21 and how it’s best-in-class product is set to disrupt the market. Watch the full video. ...
Global Health's Executive Director and former CEO, Mathew Cherian, presented at the Proactive Lifesciences investor webinar earlier today to show off the company's latest investor presentation. The key highlights addressed by Mr Cherian included the companies latest $7.8m placement with Bell Potter and Baker Young, a...